David D Schlaepfer Selected Research

David D Schlaepfer Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 02/2002
11	Carcinoma (Carcinomatosis) 06/2015 - 07/2004
9	Neoplasm Metastasis (Metastasis) 01/2015 - 12/2002
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 06/2013
4	Carcinogenesis 01/2020 - 03/2003
3	Inflammation (Inflammations) 01/2023 - 06/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2011
3	Breast Neoplasms (Breast Cancer) 05/2010 - 02/2010
2	Fibrosis (Cirrhosis) 01/2023 - 01/2016
2	Atherosclerosis 12/2021 - 04/2016
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2014
2	Ascites 08/2014 - 05/2010
1	Obesity 01/2023
1	Hyperplasia 01/2019
1	Uveal melanoma 01/2019
1	Pancreatic Ductal Carcinoma 01/2016
1	Adenoma (Adenomas) 09/2015
1	Neuroblastoma 01/2015
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 07/2014
1	Mesothelioma 07/2014
1	Wounds and Injuries (Trauma) 01/2012
1	Splenomegaly 05/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2009
1	Infections 02/2009
1	Glioma (Gliomas) 01/2006
1	Multiple Myeloma 07/2004
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2004
1	Achondroplasia 07/2004

Drug/Important Bio-Agent (IBA)

12	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022 - 03/2003
12	IntegrinsIBA 01/2018 - 01/2006
9	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 03/2003
7	Phosphotransferases (Kinase)IBA 01/2019 - 01/2006
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2007
6	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
3	CateninsIBA 01/2019 - 09/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2016 - 06/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2014 - 06/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2009 - 07/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2012
2	GastrinsIBA 06/2015 - 01/2011
2	PaxillinIBA 06/2015 - 01/2011
2	Fibronectins (Fibronectin)IBA 01/2015 - 01/2012
2	AgarIBA 08/2014 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 07/2014
2	Small Interfering RNA (siRNA)IBA 07/2014 - 06/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 10/2006
2	Epidermal Growth Factor (EGF)IBA 01/2012 - 02/2009
2	PND 1186IBA 05/2010 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 06/2007
2	Interleukin-6 (Interleukin 6)IBA 05/2010 - 06/2007
2	Drinking WaterIBA 05/2010 - 05/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	LigandsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	DNA Methyltransferase 3AIBA 12/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	Cyclin D1IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Aldehyde DehydrogenaseIBA 01/2019
1	PlatinumIBA 01/2019
1	VemurafenibIBA 01/2018
1	oxidized low density lipoproteinIBA 04/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	OsteopontinIBA 08/2014
1	Neurofibromin 2 (Merlin)IBA 07/2014
1	cadherin 5IBA 01/2014
1	TalinIBA 07/2012
1	GTP Phosphohydrolases (GTPases)IBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	tyrosine receptor (receptor, tyrosine)IBA 01/2012
1	Hormones (Hormone)IBA 01/2011
1	Growth Factor ReceptorsIBA 01/2011
1	CytokinesIBA 05/2010
1	Caspase 3 (Caspase-3)IBA 05/2010
1	Steroid Receptors (Steroid Receptor)IBA 02/2010
1	Protein Isoforms (Isoforms)IBA 02/2010
1	p120 GTPase Activating ProteinIBA 06/2009
1	ErbB Receptors (EGF Receptor)IBA 02/2009
1	Monomeric GTP-Binding ProteinsIBA 02/2009
1	integrin alphaVbeta5IBA 02/2009
1	CC ChemokinesIBA 02/2009
1	Peptide Hydrolases (Proteases)FDA Link 10/2006
1	Protein Kinases (Protein Kinase)IBA 01/2006
1	FAK-related nonkinaseIBA 01/2006
1	Metalloproteases (Metalloproteinases)IBA 01/2006
1	integrin alphavbeta1IBA 01/2006
1	Angiopoietin-2IBA 01/2006
1	Focal Adhesion Kinase 2IBA 07/2004
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2004

Therapy/Procedure

5	Therapeutics 01/2018 - 08/2008
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2019
1	Adjuvant Chemotherapy 01/2019
1	Radiotherapy 01/2018
1	Oral Administration 05/2010